Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of lung cancer with inhibitors of glutaminase

Treatment of lung cancer with inhibitors of glutaminase

US Patent 10441587 · Granted Oct 15, 2019

Estimated economic value: $2,011,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptors specific for B-cell maturation antigen and encoding p2025
Methods and combinations for treatment and T cell modulation2025
Combination of a cell therapy and a gamma secretase inhibitor2025
Method for treating cancer by disabling-BRCA1/FANCM interaction2023
Arginase inhibitor combination therapies2022
Chimeric antigen receptors specific for B-cell maturation antigen and encoding p2021
Combination therapy with glutaminase inhibitors and immuno-oncology agents2021
Combination therapy with glutaminase inhibitors2019
Combination therapy with glutaminase inhibitors and immuno-oncology agents2019
Fused pyrimidines as inhibitors of P97 complex2018
Combination therapy with glutaminase inhibitors2017
Combination therapy with glutaminase inhibitors2017